معرفی
Mathieu Ferron is a tenured Professor in the Department of Biochemistry and Molecular Medicine at the Université de Montréal. He leads the Integrative and Molecular Physiology Research Unit at the Montreal Clinical Research Institute (IRCM). His research focuses on the physiological and pathological roles of vitamin K and γ-carboxylation in energy metabolism, diabetes, and bone diseases. Ferron holds the Canada Research Chair in Bone and Energy Metabolism. His work bridges biochemistry, proteomics, and molecular biology to uncover novel mechanisms linking bone-derived hormones to systemic metabolism.
- Affiliations: IRCM, Réseau CMDO, Réseau RSBO
- Education: Ph.D. in Molecular Biology (2006, Université de Montréal), Postdoc at Columbia University (2013)
Research Interests: Vitamin K-dependent proteins, osteocalcin, β-cell function, gamma-carboxylation, metabolic diseases. His lab uses genetically modified mice, proteomics, and CRISPR-Cas9 to study how vitamin K influences diabetes and osteoporosis. Recent breakthroughs include identifying novel γ-carboxylated proteins and their roles in endocrine signaling.
Awards: 2020 Jean-Davignon Young Investigator Award, 2019 Étoiles Effervescence Prize, Pierre-Bois Excellence Award (2017).
Grants: Over $32M in funding from CIHR, Diabetes Canada, and FRQS. Current projects include vitamin K’s role in beta-cell function and γ-carboxylome characterization.
Labs/Teams: Head of the Integrative and Molecular Physiology Unit at IRCM, collaborates with the Montreal Diabetes Research Center.
